Clinical Trial Update: Metabolic Effects of Switching Kaletra to Boosted Reyataz [NA]

View source ↗

Summary

Clinical trial evaluating metabolic effects of switching from Kaletra (lopinavir/ritonavir) to boosted Reyataz (atazanavir) in HIV patients; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2010-03-03